PD-L1, generated by tumor cells, restricts the immune response of the host by binding to PD-1 on the surface of T cells, which inhibits the release of cytokines including interleukin 2 (IL2), tumor necrosis factor alpha (TNFα), and interferon gamma (IFN γ). Here, IL2 is linked to neoplasm.